Stephen Boonen

Stephen Boonen's AcademicInfluence.com Rankings

Stephen Boonen

Medical

#1889

World Rank

#2271

Historical Rank

Rheumatology

#13

World Rank

#14

Historical Rank

Epidemiology

#301

World Rank

#318

Historical Rank

medical Degrees

Stephen Boonen

Philosophy

#5590

World Rank

#8433

Historical Rank

Logic

#2842

World Rank

#3903

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Stephen Boonen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephen Boonen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. (2007) (2189)
Zoledronic acid and clinical fractures and mortality after hip fracture. (2007) (1696)
Identification of late-onset hypogonadism in middle-aged and elderly men. (2010) (1176)
Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men (2010) (1029)
Effect of 6‐Month Whole Body Vibration Training on Hip Density, Muscle Strength, and Postural Control in Postmenopausal Women: A Randomized Controlled Pilot Study (2003) (869)
Romosozumab in postmenopausal women with low bone mineral density. (2014) (801)
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. (2008) (784)
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial (2009) (737)
IOF position statement: vitamin D recommendations for older adults (2010) (701)
Interspecies differences in bone composition, density, and quality: potential implications for in vivo bone research. (1998) (692)
The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT) (2011) (588)
Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. (2007) (554)
Teriparatide or alendronate in glucocorticoid-induced osteoporosis. (2007) (510)
Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. (2010) (473)
Obesity is not protective against fracture in postmenopausal women: GLOW. (2011) (451)
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. (2010) (392)
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke (2012) (392)
Age-related changes in general and sexual health in middle-aged and older men: results from the European Male Ageing Study (EMAS). (2010) (379)
The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management. (2005) (351)
Quality of Life in Sarcopenia and Frailty (2013) (340)
Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions. (2010) (319)
Effects of denosumab on fracture and bone mineral density by level of kidney function (2011) (301)
Assessment of the strength of proximal femur in vitro: relationship to femoral bone mineral density and femoral geometry. (1997) (297)
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis (2012) (295)
Safety and Efficacy of Risedronate in Patients With Age‐Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials (2005) (294)
Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2013) (292)
Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. (2013) (290)
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis (2011) (289)
Impact of whole-body vibration training versus fitness training on muscle strength and muscle mass in older men: a 1-year randomized controlled trial. (2007) (281)
Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study (2004) (278)
Frailty and sarcopenia: definitions and outcome parameters (2012) (276)
Fracture risk and zoledronic acid therapy in men with osteoporosis. (2012) (275)
Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. (2013) (266)
Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). (2012) (258)
Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men (2012) (253)
Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment (2008) (248)
Effects of whole body vibration training on postural control in older individuals: a 1 year randomized controlled trial. (2007) (236)
Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis (2004) (234)
Coordinator-based systems for secondary prevention in fragility fracture patients (2011) (231)
The Economic Cost of Hip Fractures Among Elderly Women: A One-Year, Prospective, Observational Cohort Study with Matched-Pair Analysis (2001) (229)
Addressing the Musculoskeletal Components of Fracture Risk with Calcium and Vitamin D: A Review of the Evidence (2006) (227)
Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis. (2008) (216)
Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure (2007) (214)
Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW) (2014) (211)
Strontium Ranelate Reduces the Risk of Vertebral and Nonvertebral Fractures in Women Eighty Years of Age and Older (2006) (211)
Tools in the Assessment of Sarcopenia (2013) (207)
Quadriceps and Grip Strength Are Related to Vitamin D Receptor Genotype in Elderly Nonobese Women (1997) (198)
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. (2008) (195)
Vitamin D inadequacy among post-menopausal women: a systematic review. (2005) (195)
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. (2008) (191)
Estrogens are essential for male pubertal periosteal bone expansion. (2004) (189)
Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women. (2010) (189)
COPD, bone metabolism, and osteoporosis. (2011) (188)
Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. (2011) (187)
Update on long-term treatment with bisphosphonates for postmenopausal osteoporosis: a systematic review. (2014) (187)
Late-onset hypogonadism and mortality in aging men. (2014) (181)
Safety and Efficacy of Risedronate in Reducing Fracture Risk in Osteoporotic Women Aged 80 and Older: Implications for the Use of Antiresorptive Agents in the Old and Oldest Old (2004) (181)
Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis (2011) (180)
Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading. (2010) (180)
Do quantitative ultrasound measurements reflect structure independently of density in human vertebral cancellous bone? (1998) (178)
Association of hypogonadism with vitamin D status: the European Male Ageing Study. (2012) (178)
A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density. (2012) (177)
Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. (2003) (173)
Balloon kyphoplasty for the treatment of acute vertebral compression fractures: 2‐year results from a randomized trial (2011) (173)
Once‐Weekly Risedronate in Men With Osteoporosis: Results of a 2‐Year, Placebo‐Controlled, Double‐Blind, Multicenter Study (2009) (172)
The Effectiveness of Inpatient Geriatric Evaluation and Management Units: A Systematic Review and Meta‐Analysis (2010) (165)
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men (2009) (163)
Relative Impact of Androgen and Estrogen Receptor Activation in the Effects of Androgens on Trabecular and Cortical Bone in Growing Male Mice: A Study in the Androgen Receptor Knockout Mouse Model (2006) (162)
Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies (2005) (161)
Zoledronic Acid in Reducing Clinical Fracture and Mortality after Hip Fracture. (2007) (161)
Costs Induced by Hip Fractures: A Prospective Controlled Study in Belgium (2000) (159)
REVIEW ARTICLE: Reducing fracture risk with calcium and vitamin D (2009) (158)
Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. (2012) (158)
Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club (2009) (155)
Impact of geriatric consultation teams on clinical outcome in acute hospitals: a systematic review and meta-analysis (2013) (155)
Effects of whole body vibration training on cardiorespiratory fitness and muscle strength in older individuals (a 1-year randomised controlled trial). (2009) (155)
The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report (2004) (154)
The European Male Ageing Study (EMAS): design, methods and recruitment. (2009) (153)
Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club (2005) (152)
Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS) (2009) (152)
Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States (2009) (149)
Prediction of Vertebral Strength In Vitro by Spinal Bone Densitometry and Calcaneal Ultrasound (1997) (147)
Impact of nutrition on muscle mass, strength, and performance in older adults (2012) (146)
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures (2012) (146)
Potential mediators of the mortality reduction with zoledronic acid after hip fracture (2010) (146)
Clinical Review: Sex steroids and the periosteum--reconsidering the roles of androgens and estrogens in periosteal expansion. (2006) (146)
Strength training at high versus low external resistance in older adults: Effects on muscle volume, muscle strength, and force–velocity characteristics (2013) (144)
Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions (2012) (144)
Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture. (2007) (143)
Previous fractures at multiple sites increase the risk for subsequent fractures: The global longitudinal study of osteoporosis in women (2012) (140)
Age‐Related (Type II) Femoral Neck Osteoporosis in Men: Biochemical Evidence for Both Hypovitaminosis D– and Androgen Deficiency–Induced Bone Resorption (1997) (140)
Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis (2012) (138)
Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update (2006) (137)
The role of calcium and vitamin D in the management of osteoporosis. (2008) (136)
Increased estrogen rather than decreased androgen action is associated with longer androgen receptor CAG repeats. (2009) (132)
Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW). (2012) (132)
Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor‐α (2009) (131)
The ability of three different models of frailty to predict all-cause mortality: results from the European Male Aging Study (EMAS). (2013) (129)
The effects of whole‐body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: A 6‐month randomized, controlled trial (2011) (128)
Costs and consequences of hip fracture occurrence in old age: An economic perspective (2005) (128)
Safety and Efficacy of Teriparatide in Elderly Women with Established Osteoporosis: Bone Anabolic Therapy from a Geriatric Perspective (2006) (128)
Efficacy and Safety of a Once‐Yearly Intravenous Zoledronic Acid 5 mg for Fracture Prevention in Elderly Postmenopausal Women with Osteoporosis Aged 75 and Older (2010) (127)
Frailty and Fracture, Disability, and Falls: A Multiple Country Study From the Global Longitudinal Study of Osteoporosis in Women (2013) (127)
Musculoskeletal Rehabilitation in Osteoporosis: A Review (2004) (124)
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once‐yearly zoledronic acid 5 mg: The HORIZON‐Pivotal Fracture Trial (PFT) (2012) (124)
A fast convolution-based methodology to simulate 2-Dd/3-D cardiac ultrasound images (2009) (124)
Lower vitamin D levels are associated with depression among community-dwelling European men (2011) (123)
Antifracture Efficacy and Reduction of Mortality in Relation to Timing of the First Dose of Zoledronic Acid After Hip Fracture (2009) (123)
Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. (2002) (121)
Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper (2012) (118)
Preventing Delirium in Older Adults with Recent Hip Fracture Through Multidisciplinary Geriatric Consultation (2012) (118)
Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women. (2008) (118)
Sexual dimorphism in cortical bone size and strength but not density is determined by independent and time‐specific actions of sex steroids and IGF‐1: Evidence from pubertal mouse models (2010) (116)
Structural basis for nuclear hormone receptor DNA binding (2012) (115)
A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Management for Treating Acute Vertebral Compression Fractures (2013) (114)
Safety and efficacy of the cathepsin K inhibitor ONO‐5334 in postmenopausal osteoporosis: The OCEAN study (2011) (114)
Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis (2009) (113)
Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. (2009) (112)
Vitamin D and Calcium Insufficiency-Related Chronic Diseases: an Emerging World-Wide Public Health Problem (2009) (112)
Structural and material mechanical properties of human vertebral cancellous bone. (1997) (111)
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial (2007) (111)
Quantitative Ultrasound and Trabecular Architecture in the Human Calcaneus * (2001) (110)
Management of cancer treatment-induced bone loss in early breast and prostate cancer - a consensus paper of the Belgian Bone Club (2007) (110)
Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study (2010) (109)
Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club (2010) (108)
When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW) (2013) (106)
Changes in balance, functional performance and fall risk following whole body vibration training and vitamin D supplementation in institutionalized elderly women. A 6 month randomized controlled trial. (2009) (106)
Inverse relationship osteoarthritis-osteoporosis: what is the evidence? What are the consequences? (1996) (105)
Inhibition of Cathepsin K for Treatment of Osteoporosis (2012) (105)
Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club (2011) (104)
Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men (2010) (103)
Upper and lower gastrointestinal evaluation of elderly inpatients who are iron deficient. (1999) (103)
Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. (2013) (103)
Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club (2005) (103)
Balloon kyphoplasty and vertebroplasty in the management of vertebral compression fractures (2011) (102)
Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study. (2005) (101)
Official Positions for FRAX® clinical regarding falls and frailty: can falls and frailty be used in FRAX®? From Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. (2011) (101)
Identifying postmenopausal women with osteoporosis by calcaneal ultrasound, metacarpal digital X-ray radiogrammetry and phalangeal radiographic absorptiometry: a comparative study (2004) (101)
Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long‐term continuation on bone turnover and fracture risk—a perspective (2012) (101)
Sex steroids and the male skeleton: a tale of two hormones (2010) (100)
Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. (1999) (99)
Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletal integrity: Evidence from targeted AR disruption in mouse osteocytes (2012) (99)
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. (2013) (97)
Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial. (2012) (97)
Impaired quality of life and sexual function in overweight and obese men: the European Male Ageing Study. (2011) (97)
Renal safety in patients treated with bisphosphonates for osteoporosis: A review (2013) (96)
An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement (1999) (93)
The hinge region in androgen receptor control (2012) (93)
Relationship Between Baseline Insulin‐Like Growth Factor‐I (IGF‐I) and Femoral Bone Density in Women Aged Over 70 Years: Potential Implications for the Prevention of Age‐Related Bone Loss (1996) (92)
Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women (2012) (92)
The relationship among history of falls, osteoporosis, and fractures in postmenopausal women. (2002) (92)
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. (2009) (91)
Assessment of sexual health in aging men in Europe: development and validation of the European Male Ageing Study sexual function questionnaire. (2008) (91)
Evidence From the Aged Orchidectomized Male Rat Model That 17β‐Estradiol Is a More Effective Bone‐Sparing and Anabolic Agent Than 5α‐Dihydrotestosterone (2002) (89)
Evidence From Data Searches and Life‐Table Analyses for Gender‐Related Differences in Absolute Risk of Hip Fracture After Colles' or Spine Fracture: Colles' Fracture as an Early and Sensitive Marker of Skeletal Fragility in White Men (2004) (89)
Effects of intensive whole-body vibration training on muscle strength and balance in adults with chronic stroke: a randomized controlled pilot study. (2014) (89)
Polymorphisms of the VDR, ER and COLIA1 Genes and Osteoporotic Hip Fracture in Elderly Postmenopausal Women (2000) (89)
Factors Associated with Cortical and Trabecular Bone Loss as Quantified by Peripheral Computed Tomography (pQCT) at the Ultradistal Radius in Aging Women (1997) (88)
Effect of an Inpatient Geriatric Consultation Team on Functional Outcome, Mortality, Institutionalization, and Readmission Rate in Older Adults with Hip Fracture: A Controlled Trial (2011) (88)
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design (2009) (88)
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). (2011) (86)
Genetic determinants of heel bone properties: genome-wide association meta-analysis and replication in the GEFOS/GENOMOS consortium. (2014) (86)
Bone density and local growth factors in generalized osteoarthritis (1997) (86)
An increased rate of falling leads to a rise in fracture risk in postmenopausal women with self-reported osteoarthritis: a prospective multinational cohort study (GLOW) (2012) (86)
Association between timing of zoledronic acid infusion and hip fracture healing (2011) (85)
Musculoskeletal Frailty: A Geriatric Syndrome at the Core of Fracture Occurrence in Older Age (2012) (85)
Characteristics of older adults admitted to the emergency department (ED) and their risk factors for ED readmission based on comprehensive geriatric assessment: a prospective cohort study (2015) (85)
The association of frailty with serum 25-hydroxyvitamin D and parathyroid hormone levels in older European men. (2013) (84)
Action of androgens versus estrogens in male skeletal homeostasis. (1998) (84)
Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective. (2008) (83)
Loading and Skeletal Development and Maintenance (2010) (82)
Fall Prediction in Inpatients by Bedside Nurses Using the St. Thomas's Risk Assessment Tool in Falling Elderly Inpatients (STRATIFY) Instrument: A Multicenter Study (2007) (82)
Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW) (2010) (81)
Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. (2000) (81)
The Role of Exercise in the Treatment of Osteoporosis (2010) (80)
Steroid myopathy induced by epidural triamcinolone injection. (1995) (80)
Growth Without Growth Hormone Receptor: Estradiol Is a Major Growth Hormone‐Independent Regulator of Hepatic IGF‐I Synthesis (2005) (79)
Sex hormones, their receptors and bone health (2008) (79)
Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. (2000) (79)
1,25‐dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3‐E1 cells by direct regulation of cystathionine β‐synthase (2011) (78)
The relationships between sex hormones and sexual function in middle-aged and older European men. (2011) (77)
Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications (2012) (75)
Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. (2013) (75)
Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I (2008) (73)
Management of osteoporosis of the oldest old (2014) (72)
Impact of Androgens, Growth Hormone, and IGF‐I on Bone and Muscle in Male Mice During Puberty (2006) (71)
Variations in trabecular bone composition with anatomical site and age: potential implications for bone quality assessment (1997) (70)
Vitamin D deficiency and chronic obstructive pulmonary disease: a vicious circle. (2011) (69)
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide (2010) (69)
Age-Associated Decline in Human Femoral Neck Cortical and Trabecular Content of Insulin-Like Growth Factor I: Potential Implications for Age-Related (Type II) Osteoporotic Fracture Occurrence (1997) (68)
Effect of ONO‐5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2‐Year Results From the OCEAN Study (2014) (67)
A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Management for Treating Acute Vertebral Compression Fractures: Outcomes and Vertebral Body Kyphosis Correction and Surgical Parameters (2012) (66)
Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men (2010) (66)
Androgen receptor disruption increases the osteogenic response to mechanical loading in male mice (2010) (66)
Low prolactin is associated with sexual dysfunction and psychological or metabolic disturbances in middle-aged and elderly men: the European Male Aging Study (EMAS). (2014) (66)
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective (2006) (65)
Role of the Androgen Receptor in Skeletal Homeostasis: The Androgen‐Resistant Testicular Feminized Male Mouse Model (2004) (65)
Active vitamin D (1,25-dihydroxyvitamin D) and bone health in middle-aged and elderly men: the European Male Aging Study (EMAS). (2013) (65)
The Genetic Association of Variants in CD6, TNFRSF1A and IRF8 to Multiple Sclerosis: A Multicenter Case-Control Study (2011) (64)
Reassessment of fracture risk in women after 3 years of treatment with zoledronic acid: when is it reasonable to discontinue treatment? (2014) (64)
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men (2015) (62)
Predicting fractures in an international cohort using risk factor algorithms without BMD (2011) (62)
Frailty in Relation to Variations in Hormone Levels of the Hypothalamic–Pituitary–Testicular Axis in Older Men: Results From the European Male Aging Study (2011) (61)
Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age. (2010) (61)
Impaired bone microarchitecture at the distal radius in older men with low muscle mass and grip strength: The STRAMBO study (2013) (61)
Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study (2013) (61)
Potential of polymethylmethacrylate cement-augmented helical proximal femoral nail antirotation blades to improve implant stability—A biomechanical investigation in human cadaveric femoral heads (2012) (60)
Testosterone and the Male Skeleton: A Dual Mode of Action (2011) (58)
Force-velocity characteristics of the knee extensors: an indication of the risk for physical frailty in elderly women. (2011) (57)
Osteoporosis and the Growth Hormone-Insulin-Like Growth Factor Axis (2002) (57)
The majority of the genetic risk for Paget’s disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes (2010) (57)
Treatment of osteoporosis in men. (2004) (56)
Investigating the determinants of international differences in the prevalence of chronic widespread pain: evidence from the European Male Ageing Study (2008) (55)
Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study (1998) (55)
TDP-43 M311V mutation in familial amyotrophic lateral sclerosis (2009) (55)
Measurements of vertebral shape by radiographic morphometry: sex differences and relationships with vertebral level and lumbar lordosis (1998) (55)
Content validity and internal consistency of the Dutch translation of the Safety Attitudes Questionnaire: an observational study. (2012) (55)
Assessment of the strength of the proximal femur in vitro: relationship with ultrasonic measurements of the calcaneus. (1997) (54)
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. (2008) (54)
Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance (2008) (53)
Prediction of functional decline in older hospitalized patients: a comparative multicenter study of three screening tools (2011) (53)
Once‐Yearly Zoledronic Acid in Older Men Compared with Women with Recent Hip Fracture (2011) (53)
Preventing osteoporotic fractures with antiresorptive therapy: implications of microarchitectural changes (2004) (53)
Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts. (2011) (53)
Comparisons of Immunoassay and Mass Spectrometry Measurements of Serum Estradiol Levels and Their Influence on Clinical Association Studies in Men (2013) (52)
Osteoporosis in men. (2011) (52)
Biomechanical evaluation of bone-cement augmented Proximal Femoral Nail Antirotation blades in a polyurethane foam model with low density. (2012) (52)
Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW) (2014) (52)
Osteoporosis in older men: recent advances in pathophysiology and treatment. (2013) (51)
Hip Fracture and Osteoporosis in a XIIth Dynasty Female Skeleton from Lisht, Upper Egypt (1997) (51)
Lack of association between osteoarthritis of the hip and gene polymorphisms of VDR, COL1A1, and COL2A1 in postmenopausal women. (1998) (50)
Transmission of Whole-Body Vibration and Its Effect on Muscle Activation (2013) (50)
Thyroid hormones and male sexual function. (2012) (50)
Alternative analyses for handling incomplete follow-up in the intention-to-treat analysis: the randomized controlled trial of balloon kyphoplasty versus non-surgical care for vertebral compression fracture (FREE) (2012) (49)
Effects of anteversion on femoral bone mineral density and geometry measured by dual energy X-ray absorptiometry: a cadaver study. (1997) (48)
The Effect of Care Pathways for Hip Fractures: A Systematic Review (2012) (47)
Association of cognitive performance with the metabolic syndrome and with glycaemia in middle‐aged and older European men: the European Male Ageing Study (2010) (47)
Relationship between age-associated endocrine deficiencies and muscle function in elderly women: a cross-sectional study. (1998) (47)
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial (2010) (47)
Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men (2010) (46)
Novel insights in the regulation and mechanism of androgen action on bone (2013) (46)
Effi cacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial (2009) (45)
Health Technology Assessment in Osteoporosis (2013) (45)
Obesity, Health-Care Utilization, and Health-Related Quality of Life After Fracture in Postmenopausal Women: Global Longitudinal Study of Osteoporosis in Women (GLOW) (2014) (45)
Screening for risk of unplanned readmission in older patients admitted to hospital: predictive accuracy of three instruments (2010) (43)
Differing risk profiles for individual fracture sites: Evidence from the global longitudinal study of osteoporosis in women (GLOW) (2012) (43)
Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study (2006) (42)
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. (2008) (42)
No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain (2010) (42)
Cohort profile: the European Male Ageing Study. (2013) (42)
Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone (2010) (41)
What’s in a name? What constitutes the clinical diagnosis of osteoporosis? (2012) (41)
Non-hip, non-spine fractures drive healthcare utilization following a fracture: the Global Longitudinal Study of Osteoporosis in Women (GLOW) (2012) (41)
Femoral Neck Trabecular Microstructure in Ovariectomized Ewes Treated With Calcitonin: MRI Microscopic Evaluation (2004) (41)
Primary hyperparathyroidism: diagnosis and management in the older individual. (2004) (40)
Effect of polymorphisms in selected genes involved in pituitary-testicular function on reproductive hormones and phenotype in aging men. (2010) (40)
Gonadal sex steroid status and bone health in middle-aged and elderly European men (2010) (40)
Replication of KIF21B as a susceptibility locus for multiple sclerosis (2010) (39)
Geographic and other determinants of BMD change in European men and women at the hip and spine. a population-based study from the Network in Europe for Male Osteoporosis (NEMO). (2007) (39)
Androgens and the skeleton. (2005) (39)
Effect of Salmon Calcitonin on Femoral Bone Quality in Adult Ovariectomized Ewes (1996) (39)
Vertebral fracture risk reduction with risedronate in post-menopausal women with osteoporosis: a meta-analysis of individual patient data (2005) (38)
Assessment of non-vertebral fracture risk in postmenopausal women (2007) (38)
Frailty and sexual health in older European men. (2013) (37)
The diagnosis and treatment of male osteoporosis: Defining, assessing, and preventing skeletal fragility in men. (2007) (37)
Predictors of functional outcome following intracapsular hip fracture in elderly women. A one-year prospective cohort study. (2005) (37)
Age-related endocrine deficiencies and fractures of the proximal femur. II implications of vitamin D deficiency in the elderly. (1996) (37)
The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX. (2010) (36)
Convergent validity of the Cognitive Performance Scale of the interRAI acute care and the mini-mental state examination. (2011) (36)
Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization (2001) (36)
Randomized Trial of Alendronate Plus Vitamin D3 Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency (2011) (36)
[Falls among community-dwelling elderly: a pilot study of prevalence, circumstances and consequences in Flanders]. (2004) (36)
Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. (2012) (36)
The effectiveness of inpatient geriatric evaluation and management units: review and meta-analysis (2009) (36)
An appendix to the 2012 IOF–ECTS guidelines for the management of glucocorticoid-induced osteoporosis (2012) (36)
Ageing and calcium metabolism. (1997) (35)
Founder Effect in Different European Countries for the Recurrent P392L SQSTM1 Mutation in Paget’s Disease of Bone (2008) (35)
Physical activity in the androgen receptor knockout mouse: evidence for reversal of androgen deficiency on cancellous bone. (2009) (35)
Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density (2010) (34)
The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) (2011) (33)
Effects of a Six-Month Local Vibration Training on Bone Density, Muscle Strength, Muscle Mass, and Physical Performance in Postmenopausal Women (2015) (33)
Regional and age-related variations in the proportions of hip fractures and major fractures among postmenopausal women: the Global Longitudinal Study of Osteoporosis in Women (2012) (33)
Falls and Fractures in Postmenopausal Women: A Review (2003) (33)
Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms. (2011) (33)
Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption. (1997) (32)
Reversing sex steroid deficiency and optimizing skeletal development in the adolescent with gonadal failure. (2005) (31)
Osteoporosis and osteoporotic fractures in men: a clinical perspective. (2000) (31)
Androgens and bone (2008) (31)
Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. (2005) (31)
Long-term impact of strength training on muscle strength characteristics in older adults. (2013) (31)
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data (2012) (31)
Costs of Care After Hospital Discharge Among Women With a Femoral Neck Fracture (2003) (31)
Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. (1997) (30)
Fall incidents unraveled: a series of 26 video-based real-life fall events in three frail older persons (2013) (30)
Interrater reliability of the interRAI Acute Care (interRAI AC). (2012) (30)
Low vitamin D and the risk of developing chronic widespread pain: results from the European male ageing study (2014) (30)
Patient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium (2003) (30)
Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. (1996) (30)
The impact of care pathways for patients with proximal femur fracture: rationale and design of a cluster-randomized controlled trial (2012) (30)
The cost effectiveness of zoledronic acid 5 mg for the management of postmenopausal osteoporosis in women with prior fractures: evidence from Finland, Norway and the Netherlands (2011) (29)
Higher 25(OH)D2 is associated with lower 25(OH)D3 and 1,25(OH)2D3. (2014) (29)
Balloon kyphoplasty in patients with osteoporotic vertebral compression fractures (2012) (29)
First-generation versus third-generation comprehensive geriatric assessment instruments in the acute hospital setting: A comparison of the Minimum Geriatric Screening Tools (MGST) and the interRAI Acute Care (interRAI AC) (2011) (29)
Once‐yearly zoledronic acid and days of disability, bed rest, and back pain: Randomized, controlled HORIZON Pivotal Fracture Trial (2011) (28)
Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON–Recurrent Fracture Trial (2011) (28)
The accuracy of peripheral skeletal assessment at the radius in estimating femoral bone density as measured by dual‐energy X‐ray absorptiometry: a comparative study of single‐photon absorptiometry and computed tomography (1997) (27)
Management of patients with Paget’s disease: a consensus document of the Belgian Bone Club (2008) (27)
The effect of care pathways for hip fractures: a systematic overview of secondary studies (2012) (27)
Validity of the interRAI Acute Care based on test content: a multi-center study (2011) (27)
A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5α reductase II gene (2012) (27)
Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men (2011) (26)
Influence of bone remodelling rate on quantitative ultrasound parameters at the calcaneus and DXA BMDa of the hip and spine in middle-aged and elderly European men: the European Male Ageing Study (EMAS). (2011) (26)
Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial (2012) (26)
Effects of fitness and vibration training on muscle quality: a 1-year postintervention follow-up in older men. (2013) (26)
ASCORBATE FOR THE TREATMENT OF REFRACTORY IDIOPATHIC THKOMBOCYTOPENIC PIJRPURA (1990) (26)
Strontium ranelate and risk of vertebral fractures in frail osteoporotic women. (2011) (25)
Endogenous hormones, androgen receptor CAG repeat length and fluid cognition in middle-aged and older men: results from the European Male Ageing Study. (2010) (25)
Validation of the IOF quality of life questionnaire for patients with wrist fracture (2009) (25)
Genetic Variation in Sex Hormone Genes Influences Heel Ultrasound Parameters in Middle‐Aged and Elderly Men: Results From the European Male Aging Study (EMAS) (2009) (25)
Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover (2009) (25)
Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study. (2012) (24)
Staffing levels and the use of physical restraints in nursing homes: a multicenter study. (2014) (24)
The prevention or treatment of age‐related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF‐I or rhTGFβ): a perspective (1997) (24)
Assessment of the Relationship Between Age and the Effect of Risedronate Treatment in Women with Postmenopausal Osteoporosis: A Pooled Analysis of Four Studies (2010) (24)
Fast and accurate specimen-specific simulation of trabecular bone elastic modulus using novel beam-shell finite element models. (2011) (24)
Frailty and bone health in European men (2016) (24)
Influence of Insulin-Like Growth Factor Binding Protein (IGFBP)-1 and IGFBP-3 on Bone Health: Results from the European Male Ageing Study (2011) (24)
The Estrogen Receptor Ligand ICI 182,780 Does Not Impair the Bone-Sparing Effects of Testosterone in the Young Orchidectomized Rat Model (2002) (23)
Post-fracture management of patients with hip fracture: a perspective. (2008) (23)
Prevalence of Trabecular Microcallus Formation in the Vertebral Body and the Femoral Neck (1997) (23)
Fall Prediction According to Nurses' Clinical Judgment: Differences Between Medical, Surgical, and Geriatric Wards (2012) (23)
Restraint use in home care: a qualitative study from a nursing perspective (2014) (22)
Who should receive calcium and vitamin D supplementation? (2012) (21)
The Genomic Landscape of Prostate Cancer (2013) (21)
Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men. (2014) (21)
Relationship Between Pretreatment Rate of Bone Loss and Bone Density Response to Once‐Yearly ZOL: HORIZON‐PFT Extension Study (2015) (21)
Feasibility of implementing a practice guideline for fall prevention on geriatric wards: a multicentre study. (2013) (20)
Bone demineralisation in a large cohort of Wilson disease patients (2015) (20)
Impact of External Resistance and Maximal Effort on Force-Velocity Characteristics of the Knee Extensors During Strengthening Exercise: A Randomized Controlled Experiment (2013) (19)
The interRAI Acute Care instrument incorporated in an eHealth system for standardized and web-based geriatric assessment: strengths, weaknesses, opportunities and threats in the acute hospital setting (2013) (19)
Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. (2011) (19)
Frailty Is Associated with Impaired Quality of Life and Falls in Middle-Aged and Older European Men. (2013) (18)
Osteoporosis management: a perspective based on bisphosphonate data from randomised clinical trials and observational databases (2009) (18)
Tau levels do not influence human ALS or motor neuron degeneration in the SOD1G93A mouse (2010) (18)
Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis (2014) (18)
The Effect of Musculoskeletal Pain on Sexual Function in Middle-aged and Elderly European Men: Results from the European Male Ageing Study (2011) (18)
Polymorphisms in Genes Involved in the NF-κB Signalling Pathway Are Associated with Bone Mineral Density, Geometry and Turnover in Men (2011) (18)
Influence of Lifestyle Factors on Quantitative Heel Ultrasound Measurements in Middle-Aged and Elderly Men (2010) (18)
Development and validation of the RASP list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients): A novel tool in the management of geriatric polypharmacy (2014) (18)
Time to onset of antifracture efficacy and year‐by‐year persistence of effect of zoledronic acid in women with osteoporosis (2012) (18)
The Effect of Modifying Dietary Calcium Intake Pattern on the Circadian Rhythm of Bone Resorption (1999) (17)
Influence of Polymorphisms in the RANKL/RANK/OPG Signaling Pathway on Volumetric Bone Mineral Density and Bone Geometry at the Forearm in Men (2011) (17)
The impact of different health dimensions on overall quality of life related to kyphoplasty and non-surgical management (2013) (17)
Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid (2013) (17)
IN MIDDLE-AGED AND OLDER EUROPEAN MEN (2009) (17)
Age-related endocrine deficiencies and fractures of the proximal femur. I implications of growth hormone deficiency in the elderly. (1996) (16)
Age-related factors in the pathogenesis of senile (Type II) femoral neck fractures. (1996) (16)
TNFRSF1A coding variants in multiple sclerosis (2011) (16)
Implementation of inpatient geriatric consultation teams and geriatric resource nurses in acute hospitals: a national survey study. (2012) (16)
Risk factors for falls as a cause of hip fracture in the elderly. (1993) (16)
The correlation between the SOS in trabecular bone and stiffness and density studied by finite-element analysis (2008) (15)
Bisphosphonate efficacy and clinical trials for postmenopausal osteoporosis: Similarities and differences (2007) (15)
Health economic aspects of vertebral augmentation procedures (2015) (15)
Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men (2016) (15)
NEED FOR ADDITIONAL CALCIUM TO REDUCE THE RISK OF HIP OR ANY NONVERTEBRAL FRACTURE WITH VITAMIN D SUPPLEMENTATION: EVIDENCE FROM A COMPARATIVE META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2009) (14)
Efficacy and safety of the cathepsin K inhibitor, ONO-5334, and alendronate on post-menopausal osteopenia or osteoporosis: 2-year results from the ocean study (2011) (14)
Bone turnover markers predict hip bone loss in elderly European men: results of the European Male Ageing Study (EMAS) (2015) (14)
7α-methyl-19-nortestosterone vs. testosterone implants for hypogonadal osteoporosis: a preclinical study in the aged male orchidectomized rat model. (2011) (13)
Poor bone microarchitecture in older men with impaired physical performance—the STRAMBO study (2012) (13)
Factors associated with hip fracture occurrence in old age. Implications in the postsurgical management. (1999) (13)
Age-related bone loss and senile osteoporosis: Evidence for both secondary hyperparathyroidism and skeletal growth factor deficiency in the elderly (1995) (13)
The association between different cognitive domains and age in a multi‐centre study of middle‐aged and older European men (2009) (13)
Calcium and Vitamin D Supplementation in Men (2011) (12)
Dual energy x-ray absorptiometry-based assessment of male patients using standardized bone density values and a national reference database. (2007) (12)
Nursing staff attitudes of hip protector use in long-term care, and differences in characteristics between adherent and non-adherent residents: a survey and observational study. (2011) (12)
Growth without growth hormone receptor: Estradiol is a major growth-hormone independent regulator of hepatic insulin-like growth factor-I synthesis (2004) (11)
Subtrochanteric Fractures in Bisphosphonate-Naive Patients: Results from the HORIZON-Recurrent Fracture Trial (2011) (11)
Vertebral fracture induced by chronic contained rupture of aortic aneurysm. (1995) (11)
Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study (2011) (11)
Clinical Risk Factors for Hip Fracture in Elderly Women: A Case–Control Study (2002) (11)
A validation of the first genome-wide association study of calcaneus ultrasound parameters in the European Male Ageing Study (2011) (11)
1 , 25-Dihydroxyvitamin D 3 Influences Cellular Homocysteine Levels in Murine Preosteoblastic MC 3 T 3E 1 Cells by Direct Regulation of Cystathionine b-Synthase (2011) (10)
Falls and fractures in postmenopausal women: a review. (2003) (10)
Sustained 5-year vertebral and non-vertebral fracture risk reduction with strontium ranelate in elderly women with osteoporosis (2006) (10)
Reducing fracture risk in the oldest old: aging and the effect of pharmaceutical interventions in osteoporosis (2007) (10)
The transcription intermediary factor 1β coactivates the androgen receptor (2013) (10)
Assessment of femoral bone fragility and fracture risk by ultrasonic measurements at the calcaneus. (1998) (10)
The ESR1 (6q25) Locus Is Associated with Calcaneal Ultrasound Parameters and Radial Volumetric Bone Mineral Density in European Men (2011) (9)
Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review (2006) (9)
Androgen exposure and the maintenance of skeletal integrity in aging men (1998) (9)
Osteoporosis management: translating research into optimal fracture protection II (2008) (9)
Clinical Changes in Older Adults During Hospitalization: Responsiveness of the interRAI Acute Care Instrument (2013) (9)
Effects of once-yearly zoledronic acid 5 mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis (2010) (8)
P5C-2 A New Convolution-Based Methodology to Simulate Ultrasound Images in a 2D / 3D Sector Format (2007) (8)
Translating Fall Incidence Data into Fall-Preventive Measures in Geriatric Wards – A Survey in Belgian Hospitals (2009) (8)
Risk assessment for osteoporosis using bone mineral density determination: a belgian perspective. (1998) (8)
Colles' fracture as an early and sensitive marker of skeletal fragility in men (2003) (8)
Physiology of Calcium Homeostasis and Bone Remodeling (2004) (8)
Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture (2014) (8)
Process evaluation of a nurse-led multifactorial intervention protocol for risk screening and assessment of fall problems among community-dwelling older persons: a pilot-study. (2006) (8)
Sequential therapy in the treatment of osteoporosis (2011) (8)
First demonstration of the efficacy of an anti-osteoporotic treatment in very elderly osteoporotic women. (2004) (8)
Translation and adaption of the interRAI suite to local requirements in Belgian hospitals (2012) (8)
A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Care for Patients with Acute Vertebral Compression Fractures : One year results (2008) (7)
Sex steroids during bone growth: a comparative study between mouse models for hypogonadal and senile osteoporosis (2009) (7)
Determinants of age-associated changes in os calcis ultrasonic indices in elderly women: potential involvement of geriatric hyposomatotropism in bone fragility. (1997) (7)
Influence of Lifestyle Factors on Quantitative Heel Ultrasound Measurements in Middle-Aged and Elderly Men. (2010) (7)
The prediction of in vitro proximal femoral strength by bone mineral density and geometry measured with DXA, QCT and X-rays (1996) (7)
Comparison of 3 sequential treatment regimens of teriparatide: Final results from the EUROFORS study (2006) (6)
Fractures of the proximal femur - implications of age-related decline in muscle function (1995) (6)
Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease (2013) (6)
Epidemiological evidence against a role for C-reactive protein causing leptin resistance. (2012) (6)
Thiamine-induced anaphylactic shock. (1995) (6)
KIR2DL4 (CD158d) polymorphisms and susceptibility to multiple sclerosis (2009) (6)
Optimizing the Benefits of Bisphosphonates in Osteoporosis (2006) (5)
Low heel ultrasound parameters predict mortality in men: results from the European Male Ageing Study (EMAS) (2015) (5)
Addressing the age-related needs of osteoporotic patients with strontium ranelate (2010) (5)
Fall prediction according to nurses’ clinical judgment: Differences between medical, surgical, and geriatric wards (2012) (5)
Genetic variation in the TNFRSF11A (RANK) gene contributes to the risk to develop sporadic Paget's disease of bone (2009) (5)
EFFICACY AND SAFETY OF STRONTIUM RANELATE IN THE TREATMENT OF MALE OSTEOPOROSIS (2012) (5)
Testosterone: Testosterone and bone (2012) (5)
A Randomized Trial of Balloon Kyphoplasty and Nonsurgical Care for Acute Vertebral Compression Fracture (2009) (4)
Fall Prediction by Nurses’ Clinical Judgment: Differences between Medical, Surgical, and Geriatric Wards (2012) (4)
Primary hyperparathyroidism: pathophysiology, diagnosis and indications for surgery. (2001) (4)
Fracture risk and zoledronic acid in men with osteoporosis. (2013) (4)
EFFECT OF ZOLEDRONIC ACID THERAPY ON FRACTURE RISK IN THE TREATMENT OF MEN WITH OSTEOPOROSIS (2012) (4)
Clinical Risk Factors for Osteoporotic Hip Fracture in Elderly Women – Implications for Fracture Prevention (2001) (4)
Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis (2007) (4)
Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women (2009) (4)
Interrater reliability of the interRAI Acute Care (2010) (4)
RENAL EFFECTS OF TREATMENT WITH ZOLEDRONIC ACID: RESULTS FROM THE HORIZON-PFT EXTENSION STUDY (2012) (4)
Osteoporosis and Metabolic Bone Disease [127–142] 127. Osteoporosis, Falls and Fractures: Three Confounders in One Equation. Development and Validity of a New form for Assessment of Patients Referred for Dxa Scanning (2010) (4)
5. An International Multicenter Randomized Comparison of Balloon Kyphoplasty and Non-Surgical Management in Patients with Acute Vertebral Body Compression Fractures (2007) (4)
Impact of prevalent fractures on quality of life: global longitudinal study of osteoporosis in women (2010) (4)
Reduction of polypharmacy in geriatric inpatients using the RASP list: A cluster-randomized controlled trial (2013) (4)
Fracture protection in osteoporosis with risedronate. (2004) (3)
EPIDEMIOLOGY OF FALLS AMONG 11009 ELDERLY MEN - THE MR OS STUDY (2010) (3)
Clinicians need to treat underlying osteoporosis (2011) (3)
Anabolic effects of testosterone on bone require the presence of a functional androgen receptor in male mice (2002) (3)
Extraskeletal Risk and Protective Factors for Fractures (1998) (3)
EFFICACY AND SAFETY OF STRONTIUM RENALATE IN THE TREATMENT OF MALE OSTEOPOROSIS (2011) (3)
Impact of treatment efficacy and dosing frequency on cost-effectiveness of bisphosphonate treatment for osteoporosis: a perspective (2009) (3)
FREEDOM TRIAL: DENOSUMAB IS NOT ASSOCIATED WITH FRACTURE HEALING COMPLICATIONS IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS (2011) (3)
Comparison of three screening tools to predict hospital readmission in older adults (2012) (3)
Aging and Bone Loss (2010) (3)
Efficacy of once-yearly zoledronic acid 5 mg in men with osteoporosis with different levels of serum total testosterone (2012) (3)
FRACTURE PATTERNS WITH SELECTIVE SEROTONIN RECEPTOR INHIBITOR, PROTON PUMP INHIBITOR AND GLUCOCORTICOIDS USE IN GLOW (2014) (3)
Perturbed Insulin-like Growth Factor-1 (IGF-1) and IGF Binding Protein-3 Are Not Associated with Chronic Widespread Pain in Men: Results from the European Male Ageing Study (2009) (3)
[Recurrent falling, osteoporosis and sarcopenia, three major problems, an integrated approach]. (2009) (3)
Time to onset of anti-fracture efficacy and persistence of effect of zoledronic acid 5 mg in women with osteoporosis or recent hip fracture (2009) (3)
Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture. (2005) (3)
Strategies for the prevention of senile (type II) osteoporosis: an update (1996) (3)
Chapter 24. Gonadal Steroids (2009) (3)
Sarcopenia in ageing men: results from the european male ageing study (emas) (2010) (2)
Effects of one year vibration loading on muscle strength and hip density in postmenopausal women (2006) (2)
Medical Treatment of Age-Related Osteoporosis: Present and Future (2009) (2)
Cyrus Cooper, Anthony Woolf: Osteoporosis: best practice and research compendium (2007) (2)
The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON‐Pivotal Fracture Trial (PFT) (2012) (2)
Microstructural simulation of ultrasonic wave propagation through vertebral bone samples (2008) (2)
Antifracture efficacy and safety of once-yearly Zoledronic acid 5mg in men with osteoporosis: a prospective, randomized, controlled trial (2011) (2)
Resorption cavity depth explains strength enhancing effect of antiresorptive agents (2009) (2)
Prevalence and risk factors of co-morbidities in subjects with mild and moderate COPD detected by screening (2013) (2)
The American Society of Anesthesiologists (ASA) Physical Status Classification System Is an Independent Determinant of Long-Term Mortality in Older Patients With Hip Fracture: Systematic Review and Meta-Analysis of Longitudinal Studies (2014) (2)
Ultrasonic characterization of cancellous bone (2005) (2)
Selective and Classical Androgen Response Elements in Androgen-Regulated Gene Expression (2013) (2)
Review of comparative effectiveness of treatments to prevent fractures. (2008) (2)
Bone loss and osteoporotic fracture occurrence in aging men (2007) (2)
A phase 3 study of the efficacy and safety of Denosumab in men with low bone mineral density : design of the ADAMO (2011) (2)
Assessing the relative efficacy of different agents based on the outcomes from meta-analyses (2007) (2)
Vertebral and non-vertebral anti-fracture efficacy of strontium ranelate in very elderly women with osteoporosis (2005) (2)
Vibration Training for Upper Body: Transmission of Platform Vibrations Through Cables (2014) (2)
Fall biomechanics and osteoporotic fracture occurrence at the proximal femur: implications for the prevention of fall-related injuries (1996) (2)
Risedronate demonstrates fracture efficacy in postmenopausal women whether there is a BMD gain or loss during treatment (2006) (2)
AN INTERNATIONAL MULTICENTRE RANDOMISED COMPARISON OF BALLOON KYPHOPLASTY AND NONSURGICAL CARE IN PATIENTS WITH ACUTE VERTEBRAL BODY COMPRESSION FRACTURES (2012) (2)
DENOSUMAB DECREASES CORTICAL POROSITY IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY (2011) (2)
A Convolution-based Methodology to Simulate Cardiac Ultrasound Data Sets: Integration of Realistic Beam Profiles (2009) (2)
A novel skeleton-based finite element mesh for fast assessment of trabecular bone competence (2008) (2)
Inhibition of sclerostin with romosozumab in postmenopausal women with low BMD : phase 2 trial results (2013) (2)
Erratum to: Impact of nutrition on muscle mass, strength, and performance in older adults (2013) (1)
Biochemical composition of trabecular bone: Alterations with age and anatomical site (1996) (1)
Efficacy and safety of the cathepsin K inhibitor, ONO-5334, in the treatment of postmenopausal osteopenia or osteoporosis (2010) (1)
European Male Ageing Study Sexual Function Questionnaire (2014) (1)
Estrogen stimulates periosteal expansion in male mice, even in the context of depressed systemic levels of insulin-like growth factor-1 (2004) (1)
Colles' fracture and subsequent hip-fracture risk in men: A meta-analysis (2002) (1)
AFTER 3 YEARS OF ANNUAL ZOLEDRONIC ACID, WHO SHOULD REMAIN ON TREATMENT? RESULTS FROM THE HORIZON-PFT EXTENSION STUDY (2012) (1)
Effect of a multidisciplinary geriatric consultation on delirium and functional outcome in older hip-fracture patients (2011) (1)
Ultrasonic measurement of the calcaneus: investigation of some error sources, and correlation with femoral strength (1996) (1)
Strontium Ranelate in the Treatment of Male Osteoporosis. One Year Results of a Placebo Controlled Study (2011) (1)
Prescreening for postmenopausal osteoporosis by calcaneal ultrasound, metacarpal digital x-ray radiogrammetry and phalangeal radiographic absorptiometry: A comparative study (2003) (1)
[Delayed neurological syndrome after CO intoxication of elderly female]. (2015) (1)
Effects of 6-months vibration loading and resistance training on muscle strength and hip density in postmenopausal women: A comparative trial (2004) (1)
Muscle disorders111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study (2012) (1)
Older adults admitted to the emergency department (ED): risk factors for unplanned ED readmission (2013) (1)
Osteoporosis resulting from deficient acquisition of peak bone mass: The SAMP6 mouse model (2004) (1)
Safety Attitudes Questionnaire--Dutch Version (2012) (1)
Is Biot theory adequate to model sound wave propagation in cancellous bone (2007) (1)
Strontium ranelate reduces the risk of fracture in elderly women with osteoporosis in the first year of treatment (2006) (1)
Estrogen and the Skeleton – Rodents (2010) (1)
Androgens and Anabolic Steroids (2000) (1)
A Validated Skeleton-based Finite Element Mesh for Parametric Analysis of Trabecular Bone Competence (2009) (1)
Estrogen replacement therapy and the risk of hip fracture in old age (1996) (1)
Steroid-therapy in the elderly and fractures of the proximal femur (1995) (1)
Vitamin D deficiency and COPD (2011) (1)
EFFECT OF CO-MORBIDITIES ON FRACTURE RISK: FINDINGS FROM THE GLOW STUDY (2011) (1)
Reduction in incidence of vertebral fractures with once yearly zoledronic acid in men with osteoporosis (2011) (1)
Fracture Patterns with use of Selective Serotonin Receptor Inhibitors, Proton Pump Inhibitors and Glucocorticoids in a Large International Observational Study: GLOW (2013) (1)
Variations in trabecular bone composition with anatomical site (2006) (1)
EFFECT OF 6-YEAR TREATMENT OF OSTEOPOROSIS WITH ZOLEDRONIC ACID 5MG (ACLASTA) COMPARED WITH THE 3-YEAR-TREATMENT, RESULTS OF EXTENDED HORIZON PFT STUDY (2012) (1)
In postmenopausal women with higher fracture risk, denosumab reduced the incidence of hip and new vertebral fractures: A FREEDOM study subanalysis (2011) (1)
Evaluation of bone mineral density and calcaneal ultrasound as predictors of femoral strength (1996) (1)
Once-yearly treatment with zoledronic acid continues to be effective in old age (2009) (1)
Whole Body Vibration training in elderly women Effects on muscle strength, bone density and postural control (2004) (1)
Skeletal Sexual Dimorphism : Relative Contribution of Sex Steroids , Growth Hormone – Insulin-Like Growth Factor-I ( GH-IGF-I ) and Mechanical Loading (2010) (1)
Characteristics and effectiveness of fall prevention programs in nursing homes: A systematic review and meta-analysis of randomized controlled trials (2013) (1)
Transmission ratio distortion of DLG5 R30Q: evidence for prenatal selection? (2010) (1)
[Risk of hip fractures in the elderly: biomechanical aspects of the falling process]. (1997) (1)
The effects of whole body vibration training on postural control (2006) (1)
Development, Implementation and preliminary results of a clinical pathway "prevention of recurrent fragility fractures" (2013) (1)
Disease-specific perception of fracture risk and incident fracture rates among postmenopausal women: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW) (2013) (1)
Targeted disruption of androgen receptor in mouse osteocytes: the androgen receptor in osteocytes is important for the maintenance of bone structure in males (2012) (1)
Age-Associated Endocrine Deficiencies and Muscle Function in Elderly Women - A Cross-Sectional Study (1997) (1)
QUANTIFICATION OF TRAINING EFFECTS ON FEMORAL BONE QUALITY USING PATIENT-SPECIFIC FE ANALYSIS (2012) (1)
Generalized osteoarthritis protecting against osteoporotic fractures: Review of the evidence (1996) (1)
Low Fracture Incidence Is Maintained in Postmenopausal Women >= 75 Years with Osteoporosis with Long-Term Denosumab Treatment. (2012) (1)
Zoledronic Acid Substantially Reduces the Risk of Morphometric Vertebral and Clinical Fractures (2010) (1)
EFFICACY AND SAFETY OF ZOLEDRONIC ACID 5 MG IN PREVENTING FRACTURES IN MEN AND WOMEN AFTER HIP FRACTURE (2010) (1)
Quality of Life in Sarcopenia and Frailty (2013) (1)
Erratum: Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long‐term continuation on bone turnover and fracture risk—A perspective (2012) (1)
Late onset muscular dystrophy proximal myopathy and recurrent falls in the elderly (1995) (1)
Microstructural quality of vertebral trabecular bone can be assessed from ultrasonic wave propagation (2009) (1)
Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study Cathleen S. Colon-EmericKenneth W. LylesGuoqin SuCarl F. Pieper • Jay S. MagazinerJonathan D. AdachiChristina M. Bucci-Rechtweg • Patrick HaentjensSteven Boonenfor the HORIZON Recurrent Fracture Trial (2011) (1)
Comparison of three screening tools to predict hospital readmission and mortality in older adults (2012) (1)
Genetic variation in the aromatase gene influences heel ultrasound parameters: Results from the European male ageing study (2008) (1)
REGIONAL DIFFERENCES IN THE MANAGEMENT OF OSTEOPOROSIS. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN (2009) (1)
Management of incident fractures in an international cohort study. Global longitudinal study of osteoporosis in women (2010) (1)
Burden of non-hip–non-vertebral fractures in postmenopausal women 55 years and older. The global longitudinal study of osteoporosis in women (2009) (0)
Prediction of proximal femoral strength by DXA, QCT and radiographical measurements (1996) (0)
Association between cognitive performance and the metabolic syndrome in middle-aged and older European men (2010) (0)
Calcium and Vitamin D Supplementation inMen (2011) (0)
Senile (type II) osteoporosis: pathogenesis and prevention of estrogen deficiency-related bone loss at the proximal femur. (1995) (0)
Medical management of osteoporosis in men (2013) (0)
Fracture risk reduction with zoledronic acid by predicted fracture risk score (2011) (0)
Erratum to: Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis (2013) (0)
RASP criteria. Content validation and inter-rater reliability among Belgian pharmacists and geriatricians (2011) (0)
Validity based on test content of the Resident Assessment Instrument Acute Care: a multi-centre study (2010) (0)
The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft. (2011) (0)
Association between TGF-beta and LRP 5 & 6 genetic polymorphisms with fracture risk and bone mineral density in the EPOS study (2006) (0)
Contents Vol. 42, 1999 (1999) (0)
Reply (1998) (0)
Physical Excercise Reduces Remodeling Imbalance and Preserves Trabecular Microarchitecture in Male Mice with Androgen Receptor Disruption (2006) (0)
Genetic Variation in Wdr77 Gene Is Associated with Calcaneal Bone Ultrasound Parameters: Results from the European Male Ageing Study (2010) (0)
Inhaled corticosteroids and risk of osteoporosis in asthma ‐ reply (2005) (0)
Androgenic effects on bone and body composition depend on concerted and additive activation of both AR and ER alpha: Evidence from a new male mouse model with combined disruption of both AR and ER alpha (2007) (0)
Evaluation of a screenings program for postmenopausal osteoporosis in primary care setting in Belgium (2002) (0)
Pilot evaluation of the Carers' CARE program for the carers of people with dementia (2010) (0)
Oral communications abstracts (2007) (0)
Erratum to: Management of osteoporosis of the oldest old (2014) (0)
Thyroid Hormones and Sexual Function (2011) (0)
Weekly alendronate plus vitamin D3 5,600 IU vs. standard care: effect on serum 25(OH) vitamin D, bone turnover markers, and BMD in osteoporotic postmenopausal women with vitamin D inadequacy - 1 year results of a randomized trial (2011) (0)
Androgens, Skeletal Homeostasis, and Osteoporosis (2002) (0)
Strontium ranelate decreases the risk of hip fracture over 3 and 5 years in post menopausal women at high risk (2008) (0)
Proximal femoral strength predicted by DXA and QCT (2006) (0)
Impact of Geriatric Consultation Teams on Clinical Outcome in Acute Hospitals: a Meta-Analysis (2013) (0)
Influence of physical activity on calcaneal quantitative ultrasound (QUS): Results from the European Male Ageing Study (EMAS) (2007) (0)
Failure to Perceive Increased Risk of Fracture in Women >= 55 Years. The Global Longitudinal Registry of Osteoporosis in Women (2008) (0)
SAT0487 Denosumab (DMAB) Effect on Bone Histology and Histomorphometry in Men with Low Bone Mineral Density (BMD) (2014) (0)
Multidisciplinary geriatric consultation prevents delirium and cognitive decline in older hip fracture patients (2012) (0)
Validity based on test content of the interRAI Acute Care: a multi-centre study (2010) (0)
FRAILTY IS LINKED WITH AN INCREASED MORTALITY IN EUROPEAN MEN (2012) (0)
DISTRIBUTION OF RISK FACTORS FOR FRACTURE IN WOMEN WITH AND WITHOUT A FRACTURE HISTORY: A REGIONAL COMPARISON. THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN (2008) (0)
Pharmacologic and Non-pharmacologic Strategies to Prevent Hip Fracture in Old Age (2004) (0)
Measuring androgen receptor bioactivity in undiluted human serum: preliminary results (2012) (0)
Skeletal growth factor deficiency potentially involved in femoral bone quality loss with ageing (1995) (0)
The long-term safety and efficacy of zoledronic acid in the treatment of osteoporosis: a 3-year, randomized extension to the HORIZON-pivotal fracture trial (PFT) (2011) (0)
PAPER 195: A RANDOMIZED TRIAL OF BALLOON KYPHOPLASTY AND NONSURGICAL CARE FOR PATIENTS WITH ACUTE VERTEBRAL COMPRESSION FRACTURES (2010) (0)
Design of a prospective observational study to evaluate persistence and adherence during denosumab treatment, and patient characteristics in postmenopausal women with osteoporosis in routine clinical practice (2013) (0)
Health Technology Assessment in Osteoporosis (2013) (0)
Relationship between change in total hip BMD in response to zoledronic acid 5 mg and pre-treatment change in total hip BMD: The HORIZON-PFT Extension study (2012) (0)
125. ANATOMICAL ABNORMALITIES IN HAND OSTEOARTHRITIS ARE AFFECTED BY SOCIAL (HOBBIES) BUT NOT OCCUPATIONAL BIOMECHANICAL FACTORS (2010) (0)
Musculoskeletal Frailty: A Geriatric Syndrome at the Core of Fracture Occurrence in Older Age (2012) (0)
Sarcopenia and bone mineral density in European men (2012) (0)
Relationship between base-line serum insulin-like growth-factor-i and bone-mineral density of the femoral-neck in elderly noninstitutionalized women (1995) (0)
Estradiol recovers hepatic IGF-I gene expression in growth hormone resistant mice through activation of the JAK-STAT pathway (2005) (0)
Could the Mini-Mental State Examination be replaced by the Cognitive Performance Scale of the interRAI Acute Care? (2011) (0)
Poster 54: Impact of Zoledronic Acid on Change in Charlson Co‐morbidity Index Score and its Relationship With Mortality in Patients With Recent Hip Fracture (2009) (0)
Correlations between 25(OH)D and BMD change in postmenopausal osteoporotic women : secondary analyses of a 1-year trial of weekly alendronate (ALN) plus vitamin D3 5600 IU vs. standard care (2012) (0)
Effect of a multidisciplinary geriatric liaison intervention on clinical and functional outcome in older hip-fracture patients: a controlled trial (2011) (0)
BONE STIFFNESS STRONGLY DEPENDS ON TRABECULAR THICKNESS. A PARAMETRIC SKELETON-BASED FE STUDY (2008) (0)
Bone loss and geometric changes of human femoral cortical bone with age: an in-vitro study (1995) (0)
Comparison of four screening tools to predict functional decline in hospitalized older patients: a multicentre study (2010) (0)
Discrimination between hip and vertebral fracture patients by radius bone characteristics (2006) (0)
Search for factors influencing the ageing of testicular function in European men (2006) (0)
A skeleton-based simplified finite element model of trabecular bone (2006) (0)
COMORBIDITY INDICES FOR CLINICAL TRIALS: DEVELOPING AN INDEX USING THE FREEDOM TRIAL IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (2012) (0)
Association between cognitive performance and the metabolic syndrome in middle-aged and older European men: The European Male Ageing Study (EMAS) (2010) (0)
A RANDOMISED TRIAL OF BALLOON KYPHOPLASTY AND NONSURGICAL CARE FOR PATIENTS WITH ACUTE VERTEBRAL COMPRESSION FRACTURES, THE RESULTS AT TWO YEARS (2012) (0)
The effects of whole body vibration training in older individuals (2008) (0)
DXA-based assessment of male patients using standardized bone density values and a national reference database (2006) (0)
Abstracts for the Britspine Meeting, Newcastle 2–4 May 2012 (2012) (0)
Clinical Investigations Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis (2004) (0)
Obesity, Health-Care Utilization, and Health-Related Quality of Life After Fracture in Postmenopausal Women: Global Longitudinal Study of Osteoporosis in Women (GLOW) (2013) (0)
O1404 THE RISK OF HIP FRACTURE AFTER SUSTAINING A WRIST OR SPINE FRACTURE IN AGEING MEN AND WOMEN: A META-ANALYSIS OF PUBLISHED COHORT STUDIES (2004) (0)
Factors associated with radial trabecular and cortical bone-density measured by peripheral quantitative computed-tomography in the elderly (1995) (0)
Simulation of ultrasound wave propagation through trabecular bone samples with and without bone marrow (2008) (0)
Trabecular microcallus incidence in the lumbar vertebra and the femoral neck, and relation to bone density and modulus (1996) (0)
ACTIVE VITAMIN D (1,25-DIHYDROXYVITAMIN D) AND BONE HEALTH IN MIDDLE AGED AND OLDER MEN (2012) (0)
Bone and muscle protection and prostate-sparing effects of the selective androgen receptor modulator (SARM) 7 alpha-methyl-19-nortestosterone: Evidence from the aged orchidectomized male rat model (2004) (0)
Site-specific Associations between Fracture and Height, Weight and Body Mass Index in Postmenopausal Women: GLOW Registry (2013) (0)
Relationship Between Baseline Bone Turnover Marker Levels and Bone Mineral Density Changes in Men with Low Bone Mineral Density Receiving Denosumab or Placebo (2012) (0)
Clinical changes in older patients during hospitalization: Responsiveness of the interRAI Acute Care (2013) (0)
Pathophysiology of male osteoporosis: role of androgens and disuse (2012) (0)
Effect of once-yearly zoledronic acid in men after recent hip fracture: results from horizon recurrent fracture trial (2011) (0)
Vibration training in the elderly: Potential strategy to prevent and/or reverse sarcopenia and osteopenia (2007) (0)
The monthly oral therapy with ibandronate for osteoporosis intervention (motion) study: Rationale and design (2006) (0)
Erratum: Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long‐term continuation on bone turnover and fracture risk—A perspective (2012) (0)
Non-invasive Quantification of Changes in Bone Micro-architecture and Strength: Three Year Follow-up at the Distal Radius (2011) (0)
A multidimensional intervention strategy to reduce hip fracture risk in the elderly: Isn't it time to act? (1997) (0)
Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid (2013) (0)
Calciotropic Hormones and Indices of Bone Turnover in Femoral Neck Osteoporosis (1997) (0)
RASP: A new polypharmacy tool for the Belgian geriatric population (2010) (0)
Erratum to: Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis (2013) (0)
InterRAI Acute Care: Strategies to improve data quality (2010) (0)
Modelling of ultrasonic wave propagation through trabecular bone using a finite element model (2006) (0)
Preventing delirium in hip-fracture patients through proactive multidisciplinary geriatric consultation (2011) (0)
Best Practice & Research Clinical Endocrinology & Metabolism (2011) (0)
Belgian bone specialists are eagerly looking to the availability of new medications in osteoporosis (2006) (0)
O1144 MEDICAL CARE COSTS AFTER HOSPITAL DISCHARGE AMONG ELDERLY WOMEN WITH A FEMORAL NECK FRACTURE: A ONE-YEAR PROSPECTIVE COHORT STUDY (2004) (0)
Androgens and Skeletal Homeostasis (2003) (0)
Influence of markers of bone turnover on calcaneal quantitative ultrasound: Results from the European Male Ageing Study (EMAS) (2008) (0)
Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related loss of total body bone mineral content (2006) (0)
REPLY BY BOONEN ET AL. (2006) (0)
Efficacy of Denosumab in Increasing Hip Bone Mineral Density in Older Versus Younger Women With Postmenopausal Osteoporosis (2012) (0)
The influence of resorption cavities on trabecular bone stiffness (2008) (0)
[Involutional osteoporosis in women: therapeutic strategy. Recommendations of the Belgian Bone Club]. (2000) (0)
Review Sequential therapy in the treatment of osteoporosis (2011) (0)
Vitamin D Status and Bone Mineral Density Changes During Alendronate Treatment in Postmenopausal Osteoporosis (2013) (0)
Vitamin D status is associated with erectile dysfunction in the European Male Ageing Study (EMAS) (2010) (0)
Utility audit of Belgian DXA centers (2008) (0)
INFLUENCE OF BODY MASS INDEX AND WAIST CIRCUMFERENCE ON FRAILTY STATUS IN EUROPEAN MEN (2012) (0)
The Effect of Care Pathways for Hip Fractures: A Systematic Review (2012) (0)
Effect of Denosumab on the Incidence of Hip and New Vertebral Fractures in Postmenopausal Women With High Fracture Risk: A Subanalysis of the FREEDOM Study (2010) (0)
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-1 IS NEGATIVELY ASSOCIATED WITH CALCANEAL QUANTITATIVE ULTRASOUND (QUS) PARAMETERS: RESULTS FROM THE EUROPEAN MALE AGEING STUDY (EMAS) (2009) (0)
Osteoporosis medication in the Oldest Old (2012) (0)
Androgen action on cortical bone surfaces requires a functional androgen receptor: Evidence from the androgen receptor knock-out mouse model (2005) (0)
Treatment of BRONJ (2009) (0)
Both gonadal androgens and peripheral aromatization impact on periosteal growth during puberty in male mice (2006) (0)
Medullary bone of the laying hen - biochemical assessment of an in-vivo model of high turnover (1995) (0)
Colonization and Infection by Methicillin-Resistant Staphyliococcus Aureus in Elderly Hospitalized Patients: A Prospective Study (1995) (0)
Androgens and Bone: Clinical significance of aromatization and of partial androgen deficiency (2000) (0)
Frailty and bone health in European men 3 (2016) (0)
Type of Fracture Is an Independent Determinant of Long-Term Mortality in Older Patients With Hip Fracture: Systematic Review and Meta-Analysis of Longitudinal Studies (2014) (0)
Prevention of fragility fracture recurrences: development, implementation and preliminary research (2012) (0)
Role of Muscle Mass and Force-Velocity Characteristics of the Knee Extensors in Physical Frailty (2011) (0)
Androgens and skeletal homeostasis in men (1999) (0)
Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions (2011) (0)
Impact of nutrition on muscle strength and performance in older adults (2012) (0)
Simulation of resorption cavities in trabecular bone explains strength enhancing effect of antiresorptive agents (2009) (0)
Effect of orchidectomy on the musculoskeletal system of myostatin knockout mice (2012) (0)
Evaluation of internal geriatric consultation in Belgian hospitals (2012) (0)
Population-based geographic variations and determinants of BMD change in elderly men and women across Europe. Results from the Network for Male Osteoporosis (NEMO) study (2005) (0)
Prediction of falls in Belgian Hospitals by nurses using the Stratify instrument (2005) (0)
Measurement of the tortuosity and the viscous characteristic length of human cancellous bone via transmitted waves (2008) (0)
Prediction of femoral strength from BMD and ultrasound measurements (2006) (0)
Tissue-scale Bone Mechanical Behavior Varies between Measurement Sites and Mouse Strains (2013) (0)
ZOLEDRONIC ACID IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH HIP FRACTURE: RESULTS OF HORIZON-RFT (2011) (0)
Book Review (2001) (0)
Short communication TNFRSF1A coding variants in multiple sclerosis (2011) (0)
Center of expertise for fall & fracture prevention Flanders: Strategies to implement fall prevention in clinical practice (2012) (0)
Current developments and treatments in osteoporosis (2011) (0)
Longitudinal follow-up of androgen action on the skeleton of growing SAMP6 mouse model: No evidence for blunting of action (2005) (0)
The Hypothalamic-Pituitary-Testicular Axis and Physical Frailty in Middle Aged and Older European Men: Results from the European Male Aging Study. (2010) (0)
Case 35-2012: A Man with Weakness, Anorexia, and Diffuse Pain (2013) (0)
REASONS FOR STOPPING ANTI-OSTEOPOROSIS MEDICATIONS AMONG POSTMENOPAUSAL WOMEN: THE GLOBAL LONGITUDINAL STUDY OF OSTEOPOROSIS IN WOMEN (2010) (0)
Muscle Mass in Older Men: A 1-Year Randomized Controlled Trial Impact of Whole-Body Vibration Training Versus Fitness Training on Muscle Strength and (2015) (0)
Non-medical treatment of osteoporosis (2013) (0)
THE 6q25 LOCUS, WHICH INCLUDES THE ESR1 GENE, IS ASSOCIATED WITH HEEL ULTRASOUND PARAMETERS AND RADIAL VOLUMETRIC BMD (2010) (0)
Persistent effect of zoledronic acid in reducing the risk for fractures: pooled analysis of horizon-PFT and RFT (2010) (0)
Risedronate 150mg Once a Month in the Treatment of Postmenopausal Osteoporosis: 2 Year Efficacy and Safety Data (2009) (0)
Is er een andropauze? De European Male Ageing Study (EMAS) (2006) (0)
The correlation between SOS in trabecular bone and stiffness and density studied by FEM (2008) (0)
Aging and Sarcopenia (2008) (0)
BMD after hip fractures: Response to annual I.V. zoledronic acid 5 mg (2009) (0)
Magnitude and duration of excess mortality following hip fracture among postmenopausal women: A meta-analysis (2006) (0)
Growth Hormone - Insulin-Like Growth Factor-I (GH-IGF-I) and Mechanical Loading (2010) (0)
Re: Frailty and sexual health in older European men (2013) (0)
Subject Index Vol. 42, 1996 (1996) (0)
Implementation of multidisciplinary geriatric liaison teams in acute hospitals: a Belgian survey (2011) (0)
Spinal augmentation: what have we learnt? – Authors' reply (2009) (0)
Prevention in Old Age: Pharmacologic and Non-Pharmacologic Strategies to Prevent Hip Fracture (1998) (0)
Adverse Reactions and Drug—Drug Interactions in the Management of Women with Postmenopausal Osteoporosis (2012) (0)
A computationally efficient finite element model for ultrasound propagation through trabecular bone (2007) (0)
Microstructural simulation of ultrasonic wave propagation through vertebral trabecular bone samples (2008) (0)
Predicting functional decline in older hospitalized patients: a comparative multicenter study of four screening tools (2010) (0)
Process Evaluation of a Multifactorial Intervention Protocol for Risk Screening and Assessment of Fall Problems among Community-dwelling Elderly (2003) (0)
[Gait disorders and repeated falls in Steele-Richardson-Olszewski syndrome]. (1995) (0)
Systemic IGF-I shows concerted anabolic actions on bone and muscle: Evidence from male mice with liver-specific overexpression of IGF-I (2007) (0)
Long Term Safety of Oral Risedronate Treatment in Men with Osteoporosis as Assessed by Histomorphometry (2008) (0)
QUANTITATIVE HEEL ULTRASOUND PARAMETERS AND MORTALITY IN EUROPEAN MEN (2012) (0)
Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper (2012) (0)
Non-vertebral fracture risk of risedronate treated patients is similar to that of untreated patients 10 years younger (2009) (0)
DENOSUMAB INCREASES TOTAL HIP BONE MINERAL DENSITY IN OLDER WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (2012) (0)
Strontium ranelate demonstrates efficacy against hip fracture over 3 and 5 years in postmenopausal women at high risk of hip fracture (2008) (0)
One year whole body vibration increases muscle volume and muscle strength in older men (2006) (0)
Low levels of vitamin D in subjects with chronic widespread pain are explained by lifestyle and psychological factors: Results from the European male ageing study (EMAS) (2008) (0)
Androgens and skeletal homeostasis. Potential clinical implications of animal data (2002) (0)
Comparative study of the in vivo action of different doses of 17 beta-estradiol and dihydrotestosterone on bone in an aged male orchidectomized rat model (2001) (0)
Evidence with strontium ranelate but not bisphosphonate treatment for reduction of nonvertebral fracture risk in women over 80 years of age: a meta-analysis (2011) (0)
Variations in Bone Mineral Density with Once-Yearly i.v. Zoledronic Acid 5mg: Retrospective Subgroup Analysis of HORIZON Recurrent Fracture Trial (2009) (0)
Components of micro-architecture and bone density that contribute to biomechanical characteristics of bone. A study in ewe femora. (2005) (0)
FRACTURE INCIDENCE IN OBESE POSTMENOPAUSAL WOMEN: THE GLOBAL STUDY OF OSTEOPOROSIS IN WOMEN (GLOW) (2012) (0)
DISEASE-SPECIFIC PERCEPTION OF FRACTURE RISK AND INCIDENT FRACTURE RATES AMONG POSTMENOPAUSAL WOMEN: THE GLOW REGISTRY (2013) (0)
A geriatric liaison team caring for elderly hip-fractured patients: a randomized controlled trial (2010) (0)
Effect of denosumab on the incidence of nonvertebral fractures in postmenopausal women at increased risk of fracture: A freedom study subanalysis (study sponsored by Amgen Inc) (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephen Boonen?

Stephen Boonen is affiliated with the following schools:

KU Leuven

Stephen Boonen's Academic­Influence.com Rankings

Why Is Stephen Boonen Influential?

Stephen Boonen's Published Works

Published Works

What Schools Are Affiliated With Stephen Boonen?

Stephen Boonen's AcademicInfluence.com Rankings